Videos > Interphex 2009

Email this page News by email Send a press-release

Interphex 2009

Fresh from a fascinating trip to Interphex 2009 in New York, in-PharmaTechnologist brings you interviews with some of the drug, processing and packaging industry's leading players.

Optimising business key for pharma in downturn, says CourtSquareGroup

US strategic consultants CourtSquareGroup say that while optimisation of operations is key for the drug industry, companies risk losing the business knowledge required to undertake such action in the scramble to cut costs in the global downturn.

Compliance initiatives increase despite economy; survey

Companies are maintaining their spending on quality control measures despite the challenging operating environment, according to Matthew Kopecky, product manager at Sparta Systems.

Intelligent sorbents can save “6-12 months of development”

The use of intelligent sorbents to improve product stability can save companies six to 12 months of development and boost revenues, according to Adrian Possumato, global director at Multisorb.

PTI leak tester can “save money” over dye ingress

PTI’s non-destructive micro leak tester can cut costs for companies using dye ingress, according to general manager Heinz Wolf, who demonstrated the technology to in-PharmaTechnologist at Interphex.

Pall’s Lego-like Stax system attracts biotechs

Pall’s Stax single-use depth filter attracted interest from a “number of biotechnology companies” at Interphex, according to director of marketing Ian Sellick who explained how the system can save space, time and money.

Flexibility is key for processing sector says Millipore

Flexibility is going to be a key driver for the pharmaceutical market in the next few years, according to Millipore's VP of downstream processing Paul Chapman.

Pharma mega mergers a boon for Patheon's restructuring service, says CEO

The global economic downturn, impending blockbuster patent expiries and the wave of consolidation sweeping the pharmaceutical industry will drive demand for Patheon’s restructuring service according to CEO Wesley Wheeler.